Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending March 17, 2004. The report details a specific corporate action regarding share repurchases executed in accordance with shareholder authority granted at the Annual General Meeting on May 19, 2003.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. The only financial data disclosed relates to the share buyback transaction:
- Shares Purchased: 915,000 ordinary shares
- Purchase Date: March 16, 2004
- Price Per Share: 1086.68p
- Transaction Purpose: Cancellation of shares
Material Changes
The filing does not disclose material changes in financial performance or operations compared to prior periods. The primary change reported is the reduction of the company's share capital through the cancellation of 915,000 shares.
Guidance, Outlook, and Risks
The filing contains no management commentary, future guidance, outlook, risk factors, or contingencies. It is a procedural report of a completed share repurchase.
Key Facts for Investor Verification
- Verify the total number of shares outstanding following the cancellation of 915,000 shares.
- Confirm the total cash outflow for the repurchase (915,000 shares multiplied by 1086.68p).
- Check subsequent filings for the impact of this buyback on earnings per share (EPS).